Tower Research Capital »

Talis Biomedical Corporation shares owned by Tower Research Capital

Quarter-by-quarter ownership of Talis Biomedical Corporation (TLIS) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Talis Biomedical Corporation

Tip: Access up to 7 years of quarterly data

All positions including Talis Biomedical Corporation held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Talis Biomedical Corporation by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.1k 927 8.75
2023-09-30 $4.5k 780 5.77

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Home Depot (HD)

View all positions for Tower Research Capital

Top funds holding Talis Biomedical Corporation

Baker Bros. Advisors
Greenlight Capital
DME Capital Management
BML Capital Management
Vanguard Group
Susquehanna International
Springbok Capital Management
Geode Capital Management
BlackRock
Tower Research Capital
Morgan Stanley
ADAR1 Capital Management
Advisor Group Holdings
UBS Group
Larson Financial Group

View all funds holding Talis Biomedical Corporation